We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
With increased optimism on swift economic recovery backed by the wider rollout of COVID-19 vaccines and more stimulus, value stocks have been outperforming the growth ones. Sam Hendel of Levin Easterly Partners told Yahoo Finance last month that the value stocks have seen the largest outperformance in 2021 versus growth in the last 20 years.
Surging Treasury yields and the resultant inflationary pressure have been weighing on investors’ sentiment lately and compelled them to rotate out of the high-growth areas into the low-valued stocks. Investors should note that the value stocks were badly beaten down by the coronavirus pandemic and are thus attractively valued at the current levels (read: 5 ETFs to Ride On the Rotation to Cyclical Sectors).
With continued progress in more vaccines, rapid vaccination rollout and the prospect of further U.S. stimulus, the economy is on the mend with swift recovery expectation. The combination of factors will result in increased industrial activity and pickup in consumer demand, thereby lifting value stocks. Improvement in corporate earnings growth also bodes well for these stocks.
Further, value stocks seek to capitalize on the inefficiencies in the market and have the potential to deliver higher returns with lower volatility compared with the growth and blend counterparts. Additionally, value stocks are less susceptible to trending markets and their dividend payouts offer safety in times of market turbulence (read: US Dividends Jump to Record High Amid Pandemic: ETFs to Tap).
Given this, investors seeking to tap the current trends could consider value ETFs like iShares Focused Value Factor ETF (FOVL - Free Report) , Invesco S&P SmallCap 600 Pure Value ETF (RZV - Free Report) , Avantis U.S. Small Cap Value ETF (AVUV - Free Report) , Roundhill Acquirers Deep Value ETF (DEEP - Free Report) and Invesco S&P 500 Pure Value ETF (RPV - Free Report) . These funds offer broad exposure to the stock market and are expected to continue performing well in the coming weeks.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Why Value ETFs Are Outperforming Growth
With increased optimism on swift economic recovery backed by the wider rollout of COVID-19 vaccines and more stimulus, value stocks have been outperforming the growth ones. Sam Hendel of Levin Easterly Partners told Yahoo Finance last month that the value stocks have seen the largest outperformance in 2021 versus growth in the last 20 years.
Surging Treasury yields and the resultant inflationary pressure have been weighing on investors’ sentiment lately and compelled them to rotate out of the high-growth areas into the low-valued stocks. Investors should note that the value stocks were badly beaten down by the coronavirus pandemic and are thus attractively valued at the current levels (read: 5 ETFs to Ride On the Rotation to Cyclical Sectors).
With continued progress in more vaccines, rapid vaccination rollout and the prospect of further U.S. stimulus, the economy is on the mend with swift recovery expectation. The combination of factors will result in increased industrial activity and pickup in consumer demand, thereby lifting value stocks. Improvement in corporate earnings growth also bodes well for these stocks.
Further, value stocks seek to capitalize on the inefficiencies in the market and have the potential to deliver higher returns with lower volatility compared with the growth and blend counterparts. Additionally, value stocks are less susceptible to trending markets and their dividend payouts offer safety in times of market turbulence (read: US Dividends Jump to Record High Amid Pandemic: ETFs to Tap).
Given this, investors seeking to tap the current trends could consider value ETFs like iShares Focused Value Factor ETF (FOVL - Free Report) , Invesco S&P SmallCap 600 Pure Value ETF (RZV - Free Report) , Avantis U.S. Small Cap Value ETF (AVUV - Free Report) , Roundhill Acquirers Deep Value ETF (DEEP - Free Report) and Invesco S&P 500 Pure Value ETF (RPV - Free Report) . These funds offer broad exposure to the stock market and are expected to continue performing well in the coming weeks.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>